MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Long-term follow-up of subthalamic nucleus deep brain stimulation for Parkinson’s disease: survival and disability milestones

R. Barbosa, L. Correia-Guedes, M. Cattoni, P. Pita-Lobo, A. Castro-Caldas, M. Fabbri, P. Bastos, H. Carvalho, L. Albuquerque, S. Reimão, A. Gonçalves Ferreira, J. Ferreirajos, M. Rosa, M. Coelho (Lisbon, Portugal)

Meeting: 2022 International Congress

Abstract Number: 986

Keywords: Deep brain stimulation (DBS), Dementia, Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: To characterize retrospectively the long-term survival of 109 PD patients after 8 years of STN-DBS and to identify the incidence of the milestones of freezing, falls, hallucinations, dementia and nursing home institutionalization.

Background: Subthalamic nucleus (STN) deep brain stimulation (DBS) provides significant improvement of motor and nonmotor symptoms and quality-of-life in Parkinson’s disease (PD) patients in the short- and medium-term. However, studies on long-term survival and incidence of disability milestones outcomes after STN-DBS are rather limited

Method: 255 patients underwent surgery between 2006-2021. The clinical files from the 109 patients operated between 2006-2012 were reviewed since baseline up to 8 years (or death). For mortality, Cox proportional hazards regression analysis was performed. For disability milestones, competing risk analysis was performed and cumulative incidence functions calculated. Multivariable regression analysis in the presence of competing risks was done based on the Gray’s test of sub-distribution hazards of cumulative incidence functions.

Results: Survival rate was 83%, with a mean disease duration of 22 years. Mortality was significantly associated with age at surgery (HR 1.12, p = 0.019) and UPDRS III OFF (HR 0.94, p = 0.037). Milestones incidence was: falls 73%, freezing 47%, dementia 34%, hallucinations 32% and institutionalization 7%.  The average time from surgery to death was 62.1 ± 21.3 months, to freezing 39.6 ± 28.4 months, to falls 40.4 ± 25.4 months, to dementia 56.2 ± 21.2 months, to hallucinations 60.0 ± 20.7 months and to institutionalization 62.3 ± 22.0 months.  Age at surgery predicted falls (HR 1.284, p <0,004); age at surgery and UPDRS II OFF predicted freezing (HR 1.896, p = 0.006; HR 1.024, p < 0.001, respectively). Age at surgery and UPDRS II OFF and ON were significantly associated with dementia (HR 1.029, p=0.05; HR 1.026,  <0.001, HR 0.996, p= 0.014 respectively); and age at surgery and UPDRS II OFF predicted institutionalization (HR 1.190, p=0.001; HR 1.010, p <0.001, respectively).  

Conclusion: Disability milestones cluster together at the very late stages of disease progression and are soon followed by institutionalization and death. Age at surgery and baseline severity of the motor aspects of daily living activities appear to be the best predictors of gait and cortical milestones outcomes.

To cite this abstract in AMA style:

R. Barbosa, L. Correia-Guedes, M. Cattoni, P. Pita-Lobo, A. Castro-Caldas, M. Fabbri, P. Bastos, H. Carvalho, L. Albuquerque, S. Reimão, A. Gonçalves Ferreira, J. Ferreirajos, M. Rosa, M. Coelho. Long-term follow-up of subthalamic nucleus deep brain stimulation for Parkinson’s disease: survival and disability milestones [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/long-term-follow-up-of-subthalamic-nucleus-deep-brain-stimulation-for-parkinsons-disease-survival-and-disability-milestones/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/long-term-follow-up-of-subthalamic-nucleus-deep-brain-stimulation-for-parkinsons-disease-survival-and-disability-milestones/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley